[Form 4] AXON ENTERPRISE, INC. Insider Trading Activity
Jennifer H. Mak, Chief Accounting Officer of Axon Enterprise, Inc. (AXON), reported a sale of 77 shares of common stock on 09/15/2025. The sale was effected under a Rule 10b5-1 trading plan adopted March 14, 2025, and related to shares issued upon settlement of vested restricted stock units. The reported sale price was $760 per share. After the transaction, Ms. Mak beneficially owned 15,003 shares directly. The Form 4 was signed by an attorney-in-fact on her behalf.
- None.
- None.
Insights
TL;DR: Insider sale of 77 shares under a 10b5-1 plan; small position reduction relative to reported direct holdings.
The Form 4 discloses a routine, pre-planned disposition under a Rule 10b5-1 trading plan adopted March 14, 2025. The transaction involved 77 shares at $760 each, leaving 15,003 shares beneficially owned directly. Given the small absolute size of the sale versus reported holdings, this filing is a routine insider liquidity event rather than a material change to ownership or governance. No additional compensatory or company-level financial data is included.
TL;DR: Properly documented Rule 10b5-1 sale; disclosure and signature via attorney-in-fact are consistent with standard insider reporting practices.
The filing states the sale was executed pursuant to a 10b5-1 plan and that shares sold derived from settled vested restricted stock units. The inclusion of the plan adoption date and the attorney-in-fact signature indicates compliance with typical insider trading disclosure protocols. There are no indications of unusual timing or material governance events in this Form 4.